Personalis at Neoantigen Based Therapies Summit US: NOV 4-5, 2020


Christelle Johnson

Christelle Johnson, PhD
Senior Field Application Scientist
Personalis, Inc.

Wednesday, NOV 4 | 10:00 AM Eastern

ImmunoID NeXT: A Comprehensive Platform for Immuno-Oncology – Improving Neoantigen Prediction, Evaluating Tumor Dynamics, and Profiling Tumor Heterogeneity

  • Accurate assessment of mutational landscape and putative neoantigens from an analytically-validated platform
  • Improved neoantigen presentation prediction through machine learning built upon high-quality mono-allelic immuno-peptidomics data
  • Comprehensive immunogenomics profiling from a single sample to guide neoantigen-based therapies and biomarker discovery